Jeffrey Roberts Posted November 19, 2018 Report Share Posted November 19, 2018 Last month the US Food and Drug Administration advisory committee voted to recommend reintroduction of Zelnorm for IBS-C and for the new medication Prucalopride for chronic constipation. The IBS Patient Group provided in-person testimony at the committee meetings. Read our testimonies at https://www.ibspatient.org/advocacy Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.